Investigating the Therapeutic efficacy of GLA-IGF2 fusion enzyme with Pharmacological Chaperone ACK170 for Fabry disease
碩士 === 國立陽明大學 === 臨床醫學研究所 === 107 === Fabry disease is an X-linked inherited lysosomal storage disease with the global incidence rate from 1/40000 to 1/60000. Fabry disease is caused by mutations of GLA gene which encodes alpha-galactosidase A (α-GAL) enzyme. Complete deficiency of this enzyme alter...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2018
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/32d49v |